Table 2.
Parameter | Usual Care (N = 82) n (%) | NB + CLI (N = 71) n (%) |
---|---|---|
n a | 82 | 71 |
Improved | 21 (29.6) | |
From moderate to none | 5 (6.1) | 14 (19.7) |
From severe to none | 1 (1.2) | 2 (2.8) |
From severe to moderate | 0 (0.0) | 5 (7.0) |
No change | 61 (74.4) | 48 (67.6) |
From none to none | 37 (45.1) | 46 (64.8) |
From moderate to moderate | 17 (20.7) | 1 (1.4) |
From severe to severe | 7 (8.5) | 1 (1.4) |
Worsened | 15 (18.3) | 2 (2.8) |
From none to moderate | 9 (11.0) | 2 (2.8) |
From none to severe | 2 (2.4) | 0 (0.0) |
From moderate to severe | 4 (4.9) | 0 (0.0) |
P valueb | <0.0001 |
BES scores were categorized as follows: none = scores ≤17 indicated no significant binge eating, moderate = scores from 18 to 26 (inclusive), severe = scores ≥27 indicated severe levels of binge eating.
BES, Binge Eating Scale; CLI, comprehensive lifestyle intervention; NB, sustained release combination of naltrexone and bupropion.
The number of participants with a score at both baseline and the week 26 visit. The percentages are calculated based on this n.
From a Cochran–Mantel–Haenszel test comparing shift frequencies for participants assigned to NB + CLI to those assigned to usual care, stratified by baseline BMI category.